Equities Analysts Offer Predictions for Commercial Vehicle Group, Inc.’s Q3 2019 Earnings (NASDAQ:CVGI)

Commercial Vehicle Group, Inc. (NASDAQ:CVGI) – Research analysts at Dougherty & Co issued their Q3 2019 EPS estimates for Commercial Vehicle Group in a research note issued on Wednesday, August 28th. Dougherty & Co analyst M. Shlisky anticipates that the company will post earnings of $0.33 per share for the quarter. Dougherty & Co has a “Neutral” rating on the stock. Dougherty & Co also issued estimates for Commercial Vehicle Group’s FY2019 earnings at $1.26 EPS and FY2020 earnings at $0.68 EPS.

Equities Analysts Increase Earnings Estimates for Designer Brands Inc (NYSE:DBI)

Designer Brands Inc (NYSE:DBI) – William Blair increased their Q4 2020 earnings per share estimates for shares of Designer Brands in a report issued on Thursday, August 29th. William Blair analyst D. Carden now forecasts that the company will post earnings of $0.31 per share for the quarter, up from their previous forecast of $0.30. William Blair also issued estimates for Designer Brands’ Q4 2021 earnings at $0.35 EPS and FY2021 earnings at $2.16 EPS.

Equities Analysts Reduce Earnings Estimates for Host Hotels and Resorts Inc (NYSE:HST)

Host Hotels and Resorts Inc (NYSE:HST) – Research analysts at Capital One Financial decreased their Q3 2019 earnings estimates for shares of Host Hotels and Resorts in a research report issued on Wednesday, August 14th, according to Zacks Investment Research. Capital One Financial analyst N. Malkin now anticipates that the real estate investment trust will post earnings of $0.37 per share for the quarter, down from their previous forecast of $0.40. Capital One Financial has a “Overweight” rating and a $23.00 price objective on the stock. Capital One Financial also issued estimates for Host Hotels and Resorts’ Q4 2019 earnings at $0.39 EPS, FY2019 earnings at $1.78 EPS, Q1 2020 earnings at $0.42 EPS, Q2 2020 earnings at $0.55 EPS, Q3 2020 earnings at $0.38 EPS, Q4 2020 earnings at $0.41 EPS, FY2020 earnings at $1.76 EPS, Q1 2021 earnings at $0.43 EPS, Q2 2021 earnings at $0.56 EPS and FY2021 earnings at $1.78 EPS.

Equities Analysts Reduce Earnings Estimates for Comcast Co. (NASDAQ:CMCSA)

Comcast Co. (NASDAQ:CMCSA) – Investment analysts at Oppenheimer decreased their Q3 2019 EPS estimates for Comcast in a research note issued to investors on Friday, August 16th, according to Zacks Investment Research. Oppenheimer analyst T. Horan now forecasts that the cable giant will earn $0.77 per share for the quarter, down from their prior estimate of $0.78. Oppenheimer also issued estimates for Comcast’s FY2020 earnings at $3.58 EPS.

Equities Analysts Offer Predictions for Cardiovascular Systems Inc’s Q2 2020 Earnings (NASDAQ:CSII)

Cardiovascular Systems Inc (NASDAQ:CSII) – Analysts at Svb Leerink cut their Q2 2020 earnings per share (EPS) estimates for shares of Cardiovascular Systems in a research note issued on Tuesday, August 6th, according to Zacks Investment Research. Svb Leerink analyst D. Antalffy now expects that the medical device company will post earnings per share of $0.02 for the quarter, down from their previous forecast of $0.04. Svb Leerink also issued estimates for Cardiovascular Systems’ Q3 2020 earnings at $0.02 EPS, Q4 2020 earnings at $0.05 EPS, Q1 2021 earnings at ($0.03) EPS, Q3 2021 earnings at $0.09 EPS and Q4 2021 earnings at $0.12 EPS.

Equities Analysts Offer Predictions for Sterling Construction Company, Inc.’s Q3 2019 Earnings (NASDAQ:STRL)

Sterling Construction Company, Inc. (NASDAQ:STRL) – Research analysts at DA Davidson reduced their Q3 2019 EPS estimates for shares of Sterling Construction in a report issued on Wednesday, August 7th, Zacks Investment Research reports. DA Davidson analyst B. Thielman now forecasts that the construction company will post earnings of $0.41 per share for the quarter, down from their previous estimate of $0.42.

Equities Analysts Issue Forecasts for BioMarin Pharmaceutical Inc.’s FY2021 Earnings (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) – Analysts at Gabelli upped their FY2021 earnings estimates for BioMarin Pharmaceutical in a report released on Monday, August 5th, Zacks Investment Research reports. Gabelli analyst J. He now anticipates that the biotechnology company will post earnings of $1.57 per share for the year, up from their previous forecast of $1.42.

Equities Analysts Issue Forecasts for AES Corp’s Q3 2019 Earnings (NYSE:AES)

AES Corp (NYSE:AES) – Stock analysts at SunTrust Banks issued their Q3 2019 earnings per share (EPS) estimates for shares of AES in a research report issued to clients and investors on Tuesday, August 6th, according to Zacks Investment Research. SunTrust Banks analyst A. Agha expects that the utilities provider will post earnings of $0.40 per share for the quarter. SunTrust Banks also issued estimates for AES’s Q4 2019 earnings at $0.40 EPS.

Equities Analysts Issue Forecasts for Valero Energy Co.’s Q3 2019 Earnings (NYSE:VLO)

Valero Energy Co. (NYSE:VLO) – Equities research analysts at Piper Jaffray Companies issued their Q3 2019 earnings per share (EPS) estimates for Valero Energy in a research report issued to clients and investors on Tuesday, August 6th, according to Zacks Investment Research. Piper Jaffray Companies analyst P. Flam forecasts that the oil and gas company will earn $1.82 per share for the quarter. Piper Jaffray Companies also issued estimates for Valero Energy’s Q4 2019 earnings at $1.47 EPS, FY2019 earnings at $5.14 EPS, Q1 2020 earnings at $1.52 EPS, Q2 2020 earnings at $3.07 EPS, Q3 2020 earnings at $2.64 EPS, Q4 2020 earnings at $1.74 EPS and FY2020 earnings at $8.97 EPS.

Equities Analysts Issue Forecasts for Mirati Therapeutics Inc’s Q3 2019 Earnings (NASDAQ:MRTX)

Mirati Therapeutics Inc (NASDAQ:MRTX) – Investment analysts at SunTrust Banks upped their Q3 2019 earnings per share (EPS) estimates for shares of Mirati Therapeutics in a report issued on Monday, August 5th, Zacks Investment Research reports. SunTrust Banks analyst P. Lawson now expects that the biotechnology company will post earnings of ($1.15) per share for the quarter, up from their prior estimate of ($1.19). SunTrust Banks currently has a “Buy” rating and a $120.00 target price on the stock. SunTrust Banks also issued estimates for Mirati Therapeutics’ Q4 2019 earnings at ($1.14) EPS, FY2019 earnings at ($4.73) EPS, FY2020 earnings at ($5.23) EPS, FY2021 earnings at ($3.40) EPS and FY2022 earnings at $0.45 EPS.

error: Content is protected !!